BrightSpring Health Services, Inc. (BTSG) FY2026 Q2 P&L / Income Statement

BrightSpring Health Services, Inc. (BTSG) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

3,873,140,000 US dollars

Cost of revenue (calculated)

3,380,394,000 US dollars

Gross profit

492,746,000 US dollars

Operating expenses (calculated)

362,355,000 US dollars

Operating income

130,391,000 US dollars

Other income (expense), net (calculated)

negative 36,879,000 US dollars

Income from continuing operations before income taxes

93,512,000 US dollars

Income tax expense

6,908,000 US dollars

Net income

84,209,000 US dollars

Pharmacy Solutions

3,407,100,000 US dollars

Provider Services

466,000,000 US dollars

Undisclosed (calculated)

40,000 US dollars

Cost of goods

3,108,992,000 US dollars

Cost of services

271,402,000 US dollars

Selling, general, and administrative expenses

362,355,000 US dollars

(Loss) income from discontinued operations, net of income taxes

negative 2,395,000 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
• Of which attributable to BrightSpring Health Services, Inc.: $84.29 M; to noncontrolling interests: −$81.00 K.